USPTO serial 79451629
LEICA
Reviewed by CopyMark Law Group
Status 641Office Action
- Filing date
- Status date
- Registration date
- —
- Examiner
- TATE-NAGHI, JACQUELINE P
- Law office
- TMO LAW OFFICE 120
What this means
The USPTO has issued an Office Action on this application. A response is typically required before the deadline, or the application can be abandoned.
Need help with LEICA?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Office Action, set up monitoring, or talk with CopyMark.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Chemicals for use in industry and science; chemical reagents for non-medical purposes; research reagents and preparations, except for medical or veterinary use; research preparations used in science; chemical reagents and diagnostic preparations for use in research laboratories and for use in industry; chemical preparations for fluorescent dyes and for use in marking or labelling in industry and science; assay reagents for use in research, quality control, diagnostic use [industrial]; aptamers for use in research, quality control; affinity reagents for use in research or quality control; chemical preparations of supramolecular host-guest systems for use in research or quality control; reagents containing primary antibodies, aptamers, affimers, or other affinity reagents, nucleic acid probes, fluorescent dyes, fluorescent labels, non-optically detectable labels, blocking agents, inactivation agents for research use; reagents for research purposes; reagents containing primary antibodies for research use; chemical reagents for research purposes; clinical research reagents; chemical reagents for medical or veterinary research purposes, namely reagents for immuno-histochemistry detection and in situ-hybridisation detection; in situ-hybridisation probes for medical research purposes; epitope retrieval solutions for medical research purposes; enzymes and enzyme preparations for medical research purposes; histological dye and stain solutions for medical research purposes; preparations for medical and veterinary research; research preparations, namely antibodies or nucleic acid probes, for the investigation of disease models; diagnostic preparations for scientific or research use; preparations being dewaxing and wash buffers used with the aforementioned preparations; kits comprising a combination of any of the before. | ACTIVE | — |
| 005 | Diagnostic preparations for medical use; medical preparations for fluorescent dyes and for use in marking or labelling in medical diagnostic use; assay reagents for diagnostic use; aptamers for diagnostic use; affinity reagents for diagnostic use; medical preparations of supramolecular host-guest systems for diagnostic use; reagents containing primary antibodies, aptamers, affimers, or other affinity reagents, nucleic acid probes, fluorescent dyes, fluorescent labels, non-optically detectable labels, blocking agents, inactivation agents for diagnostic use; preparations being dewaxing and wash buffers used with the aforementioned preparations; kits comprising a combination of any of the before. | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Oct 1, 2026 | RFNT | REFUSAL PROCESSED BY IB | — |
| Sep 24, 2026 | LIMG | LIMITATION OF GOODS RECEIVED FROM IB | — |
| Sep 5, 2026 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Sep 5, 2026 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Jun 24, 2026 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Jun 23, 2026 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 13, 2026 | DOCK | ASSIGNED TO EXAMINER | — |
| Jun 12, 2026 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Jun 12, 2026 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jun 11, 2026 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |